EUVIMEDEUVIMED entdecken
Open Access

Dominant NARS1 mutations causing axonal Charcot–Marie–Tooth disease expand NARS1 -associated diseases

Danique Beijer iD, Sheila Marte, Jiaxin C Li, Willem De Ridder, Jessie Z Chen, Abigail L D Tadenev, Kathy E Miers, Tine Deconinck, Richard Macdonell, Wilson Marques, Peter De Jonghe, Samia L Pratt und 5 weitere

Brain Communications · 01.03.2024 · 6 (2)

DOI: 10.1093/braincomms/fcae070 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain Communications, online erschienen am 08.03.2024. Verfasst von Danique Beijer und 16 weiteren Autor:innen. Beteiligte Einrichtung: Translational Neurosciences, Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, B-2610, Belgium. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NINDS NIH HHS, Humboldt Research Fellowship Programme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pathogenic variants in six aminoacyl-tRNA synthetase (ARS) genes are implicated in neurological disorders, most notably inherited peripheral neuropathies. ARSs are enzymes that charge tRNA molecules with cognate amino acids. Pathogenic variants in asparaginyl-tRNA synthetase (NARS1) cause a neurological phenotype combining developmental delay, ataxia and demyelinating peripheral neuropathy. NARS1 has not yet been linked to axonal Charcot–Marie–Tooth disease. Exome sequencing of patients with inherited peripheral neuropathies revealed three previously unreported heterozygous NARS1 variants in three families. Clinical and electrophysiological details were assessed. We further characterized all three variants in a yeast complementation model and used a knock-in mouse model to study variant p.Ser461Phe. All three variants (p.Met236del, p.Cys342Tyr and p.Ser461Phe) co-segregate with the sensorimotor axonal neuropathy phenotype. Yeast complementation assays show that none of the three NARS1 variants support wild-type yeast growth when tested in isolation (i.e. in the absence of a wild-type copy of NARS1), consistent with a loss-of-function effect. Similarly, the homozygous knock-in mouse model (p.Ser461Phe/Ser472Phe in mouse) also demonstrated loss-of-function characteristics. We present three previously unreported NARS1 variants segregating with a sensorimotor neuropathy phenotype in three families. Functional studies in yeast and mouse support variant pathogenicity. Thus, NARS1 is the seventh ARS implicated in dominant axonal Charcot–Marie–Tooth disease, further stressing that all dimeric ARSs should be evaluated for Charcot–Marie–Tooth disease.

Schlagwörter

Stichwörter der Autor:innen

Charcot–Marie–Tooth diseaseNARS1aminoacyl-tRNA synthetasesasparaginyl-tRNA synthetaseaxonal sensorimotor neuropathy

Autor:innen und Institutionen

  • Translational Neurosciences, Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, B-2610, Belgium.
  • Laboratory of Neuromuscular Pathology, Institute Born-Bunge, University of Antwerp, Wilrijk, B-2610, Belgium.
  • Department for Human Genetics and John P. Hussman Institute for Human Genomics, University of Miami, Miami, FL 33136, USA.
  • Department of Human Genetics, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
  • The Jackson Laboratory, Bar Harbor, ME 04609, USA.
  • Genetics Program, Graduate School of Biomedical Sciences, Tufts University, Boston, MA 02111, USA.

ORCID-Profile: Danique Beijer, Stephan Züchner, Anthony Antonellis, Robert W Burgess, Jonathan Baets

Förderung

  • NIGMS NIH HHS
  • NINDS NIH HHS
  • Humboldt Research Fellowship Programme
  • Michigan Pre-doctoral Training Program in Genetics
  • National Research Service Award
  • National Institute of Neurological Diseases and Stroke
  • National Institute of General Medical Sciences
  • National Institutes of Health

Zitieren

APA

Beijer, D., Marte, S., Li, J. C., De Ridder, W., Chen, J. Z., Tadenev, A. L. D., Miers, K. E., Deconinck, T., Macdonell, R., Marques, W., De Jonghe, P., Pratt, S. L., Meyer-Schuman, R., Züchner, S., Antonellis, A., Burgess, R. W., & Baets, J. (2024). Dominant NARS1 mutations causing axonal Charcot–Marie–Tooth disease expand NARS1 -associated diseases. Brain Communications, 6(2). https://doi.org/10.1093/braincomms/fcae070

Vancouver

Beijer D, Marte S, Li JC, De Ridder W, Chen JZ, Tadenev ALD, et al. Dominant NARS1 mutations causing axonal Charcot–Marie–Tooth disease expand NARS1 -associated diseases. Brain Communications. 2024;6(2). doi:10.1093/braincomms/fcae070

BibTeX
@article{Beijer2024,
  author = {Beijer, Danique and Marte, Sheila and Li, Jiaxin C and De Ridder, Willem and Chen, Jessie Z and Tadenev, Abigail L D and Miers, Kathy E and Deconinck, Tine and Macdonell, Richard and Marques, Wilson and De Jonghe, Peter and Pratt, Samia L and Meyer-Schuman, Rebecca and Züchner, Stephan and Antonellis, Anthony and Burgess, Robert W and Baets, Jonathan},
  title = {Dominant NARS1 mutations causing axonal Charcot–Marie–Tooth disease expand NARS1 -associated diseases},
  journal = {Brain Communications},
  year = {2024},
  volume = {6},
  number = {2},
  doi = {10.1093/braincomms/fcae070}
}
Kostenlos starten →